Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.2
2.9
Journals
JCM
Special Issues
Clinical Advances in Urologic Oncology: 2nd Edition
jcm-logo
Submit to JCM Review for JCM Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Clinical Advances in Urologic Oncology: 2nd Edition

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".

Deadline for manuscript submissions: closed (20 January 2026) | Viewed by 546

Special Issue Editor

Dr. Saum Ghodoussipour

E-Mail Website
Guest Editor
Division of Urology, Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson University Hospital, 195 Albany St., New Brunswick, NJ 08901, USA
Interests: urologic oncology; bladder cancer; urothelial cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The world of urologic oncology is rapidly evolving. Within the realm of bladder, prostate, kidney, testis, and penile cancers, new treatment paradigms, medications, and surgical modifications are evolving in parallel with progressive research on these topics. For example, in bladder cancer, novel intravesical and targeted therapies are gaining traction. For prostate cancer, advanced imaging and less-invasive focal therapy have been increasingly utilized. These examples just begin to scratch the surface of the recent developments in our field. For this Special Issue, we encourage authors to submit papers on recent clinical updates on urologic cancer that interest them. This is a new volume; we published five papers in the first volume. For more details, please visit https://www.mdpi.com/journal/jcm/special_issues/60K1567Y5L.

Dr. Saum Ghodoussipour
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bladder cancer
  • kidney cancer
  • prostate cancer
  • testis cancer
  • penile cancer
  • minimally invasive
  • cancer treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

10 pages, 765 KB  
Article
Anatomical Refinement of Pelvic Lymphadenectomy in Extraperitoneal Radical Prostatectomy Based on a Constant Venous Landmark
by Bogdan Petrut, Roxana Andra Coman, Sara Arif-Miscov, Bogdan Coste and Teodor Maghiar
J. Clin. Med. 2026, 15(1), 156; https://doi.org/10.3390/jcm15010156 - 25 Dec 2025
Viewed by 313
Abstract
Background/Objectives: Extended pelvic lymph node dissection (ePLND) is the standard approach for staging intermediate- and high-risk prostate cancer (PCa), but the optimal extent of the procedure is still being debated due to the need to balance staging benefits with postoperative complications. This [...] Read more.
Background/Objectives: Extended pelvic lymph node dissection (ePLND) is the standard approach for staging intermediate- and high-risk prostate cancer (PCa), but the optimal extent of the procedure is still being debated due to the need to balance staging benefits with postoperative complications. This study aimed to assess whether the deep circumflex iliac vein, a consistent anatomical venous landmark, can guide a more selective dissection template that maintains staging accuracy while reducing morbidity. Methods: We conducted a retrospective analysis of 32 patients with intermediate- or high-risk PCa and histologically confirmed nodal metastases who underwent minimally invasive extraperitoneal radical prostatectomy with ePLND between 2018 and 2024. The lymph nodes located above (supra-venous) and below (infra-venous) the landmark vein were dissected separately and analysed histologically. Postoperative lymphoceles and related complications were recorded. Results: No metastatic lymph nodes were found in the subvenous region across all patients. All positive nodes were located cranially to the landmark, primarily in the obturator, internal iliac and proximal external iliac regions. Lymphoceles occurred in all patients, 62.5% of whom were symptomatic, 43.8% of whom had a fever, and 18.8% of whom were septic and required drainage. Four patients underwent laparoscopic reintervention for recurrent lymphoceles. Conclusions: The absence of metastatic involvement in the subvenous region suggests it is an oncologically low-yield zone. A refined dissection template omitting this area, guided by a reproducible venous landmark, may lower complication rates without compromising staging accuracy. Prospective validation is warranted before clinical adoption. Full article
(This article belongs to the Special Issue Clinical Advances in Urologic Oncology: 2nd Edition)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop